Live
LabiotechViral vector production: How CDMOs influence late-stage development successeLifeAre interphylum spiralian relationships resolvable?FierceBiotechSpyre spies another edge for UC ambitions with midstage win for anti-TL1A antibodyClinical OMICsGenetics of How Steroids Are Metabolized Impacts Adverse EventsClinical OMICsCellular Biological Age Test Can Predict Disease Risk and SurvivalFierceBiotechJapan, South Korea challenge the West’s place in research rankings: reportEndpoints NewsCMS seeks to close Medicare negotiation 'loophole'Endpoints NewsFDA plans to keep Makary priorities on trials, China, deputy saysClinical OMICsTwo Women, One Mission: Closing the Gap Between Cancer Science and SurvivalEndpoints NewsTakeda fortifies orexin potential with more Phase 3 dataBioWorldAppointments and advancements for June 15, 2026BioWorldFinancings for June 15, 2026
10x Genomics Blog Mar 17, 2026

10x Genomics (NASDAQ:TXG) Stock Price Up 6.9% - Time to Buy? - MarketBeat

10x Genomics (NASDAQ:TXG) Stock Price Up 6.9% - Time to Buy? - MarketBeat

Body unavailable. Use the original source.